Differential (Click to cross reference) Addison's disease adrenoleukodystrophy adrenoleukodystrophy, adult onset adrenoleukodystrophy, carrier adrenomyeloneuropathy adverse drug reaction asymptomatic attention deficit disorder with hyperactivity bone marrow transplantation children cultured skin fibroblasts dementia, childhood demyelinating disease diet dysarthria-clumsy hand syndrome dysphagia epidemiology of neurology erucic acid therapy fatty acid, elevated plasma content gene gene therapy genetic counselling genetic diagnosis, prenatal genetic neurologic disorders genetic screening genetic testing hormone replacement hypogonadism leukodystrophy Lorenzo's oil misdiagnosis MRI MRI, abnormal multiple sclerosis, misdiagnosis neurologic disease, diagnoses of neurologic signs oleic acid therapy paraparesis, spastic peroxisomal disease prenatal diagnosis by amniocentesis prevention of neurologic disorders prognosis review article seizure skin, darkening of testicular atrophy treatment of neurologic disorder very long chain fatty acids visual evoked response white matter disease

Showing articles 50 to 56 of 56 << Previous Drug-Induced Myopathies In Man Lancet 2:562-566, Lane,R.J.M.,et al, 1978 Clofibrate-Induced Muscle Damage with Myoglobinuria & Cardiomyopathy NEJM 296:942, Smals,A.G.H., 1977 Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease NEJM 293:174, Genton,E.,et al, 1975 Specific Laboratory Test for Diagnosis of MS BMJ 1:412, Field,E.J.,et al, 1974 The Treatment of Cerebrovascular Disease with Clofibrate VA Cooperative Study Group, Stroke 4:6841973., , 1973 Muscular Syndrome after Clofibrate NEJM 286:1110, Katsilambros,N., 1972 Clofibrate for the Treatment of Occlusive CVD-Correspondence NEJM 287:671, Hirsch,S.,et al, 1972 Showing articles 50 to 56 of 56 << Previous